… tumor expressing mouse GPC3 both in vitro and in vivo (10). Because the structural motifs
of peptides bound to HLA-A24 (A*… as a cancer immunotherapy modality for HLA-A24 + HCC …

… Hepatocellular carcinoma (HCC) is the most common type of liver cancer with limited … )
-engineered T-cell immunotherapies specific for human leukocyte antigen (HLA) -A*02:01-…

… In our study, we examined 38 HLA-A24 positive patients with HCC who were admitted to
Kanazawa University Hospital between January 2002 and August 2003, consisting of 30 men …

… tumor expressing mouse GPC3. Because of similarities in the binding peptide motifs between
H-2K(d) and HLA-A24 (… be useful for the immunotherapy of HLA-A24(+) patients with HCC …

… More than 50% of infected patients will develop chronic hepatitis, and some of those will
progress to hepatocellular carcinoma [3]. While the pathogenic mechanism of the hepatocellular …

… To investigate whether Sur79L2 can induce Survivin-specific anti-hepatocellular carcinoma
(… In the HLA-A24 blocking experiment, anti-HLA-A24 mAb 22E1 markedly inhibited cytotoxic …

… , if presented with human leukocyte antigen (HLA) molecules, … The MAGE-A expression profile
of hepatocellular carcinomas … immunotherapy, and HLA-A24 is commonly observed (60%) …

… Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease and hepatocellular
carcinoma worldwide. However, causes of the high persistent infection rate with HCV …

… Cytotoxic T lymphocytes (CTLs) induced by the fusion cells were able to kill autologous
HCC by HLA-A2- and/or HLA-A24-restricted mechanisms. CTL activity against shared TAAs …

… This study also showed that the SART1259 antigen on the HLA-A24 molecules of HCC
cells could be recognized by the CTLs, and the SART 1-derived peptide induced the HLAA24- …